References
- Anon. (2009). SYNCHRON° Systems Magnesium Chemistry Information Sheet. Fullerton, CA: Beckman Coulter.
- Craig, S. B., Graham, G. C., Burns, M.-A., Dohnt, M. F., Smythe, L. D. & McKay, D. B. (2009a). Haematological and clinical-chemistry markers in patients presenting with leptospirosis: a comparison of the findings from uncomplicated cases with those seen in the severe disease. Annals of Tropical Medicine and Parasitology, 103, 333-341.
- Craig, S. B., Graham, G. C., Burns, M.-A., Dohnt, M. F., Smythe, L. D. & McKay, D. B. (2009b). Hypomagnesemia in acute leptospirosis. American Journal of Tropical Medicine and Hygiene, 80, 1067.
- De Jorge, F. B. (1970). Concentraciies de cobre, ceruloplasmina, magnésio e sulfato no sangue de pacientes com a forma hepato—rebak da diebga de Weil. Revista Brasileira de Medicina, 27, 449–451.
- Esen, S., Sunbul, M., Leblebicioglu, H., Eroglu, C. & Turan, D. (2004). Impact of clinical and laboratory findings on prognosis in leptospirosis. Swiss Medical Weekly, 134, 347-352.
- Faine, S. (1982). Guidelines for the Control of Leptospirosis, Geneva: World Health Organization.
- Faine, S., Adler, B., Bolin, C. & Perolat, P. (1999). Leptospira and Leptospirosis, 2nd Edn. Melbourne, Australia: MediSci.
- Khositseth, S., Sudjaritjan, N., Tananchai, P., Ong-ajyuth, S., Sitprija, V. & Thongboonkerd, V. (2008). Renal magnesium wasting and tubular dysfunction in leptospirosis. Nephrology, Dialysis, Transplantation, 23, 952–958.
- Marotto, P. C. F., Nascimento, C. M. R., Eluf-Neto, J., Marotto, M. S., Andrade, L., Sztajnbok, J. & Seguro, A. C. (1999). Acute lung injury in leptos-pirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clinical Infectious Diseases, 29, 1561–1563.
- McClain, J. B., Ballou, W. R., Harrison, S. M. & Steinweg, D. L. (1984). Doxycyclin therapy for leptospirosis. Annals of Internal Medicine, 100, 696–698.
- Panaphut, T., Domrongkitchaiporn, S., Vibhagool, A., Thinkamrop, B. & Susaengrat, W. (2003). Ceftriaxone compared with sodium penicillin G for the treatment of severe leptospirosis. Clinical Infectious Diseases, 36, 1508–1513.
- Spichler, A., Athanazio, D. A., Furtado, J., Seguro, A. & Vinetz, J. M. (2008). Severe, symptomatic hypomagnesemia in acute leptospirosis. American Journal of Tropical Medicine and Hygiene, 79, 915–917.
- Suputtamongkol, Y., Niwattayakul, K., Suttinont, C., Losuwanaluk, K., Limpaiboon, R., Chierakul, W., Wuthiekanun, V., Triengrim, S., Chenchittikul, M. & White, N. J. (2004). An open randomized, controlled trial of penicillin, doxycycline and cefotax-ime for patients with severe leptospirosis. Clinical Infectious Diseases, 39, 1417–1424.
- Swaminathan, R. (2003). Magnesium metabolism and its disorders. Clinical Biochemistry Reviews, 24, 47–66.
- Watt, G., Padre, L. P., Tuazon, M. L., Calubaquib, C., Santiago, E., Ranoa, C. P. & Laughlin, L. W. (1988). Placebo-controlled trial of intravenous peni-cillin for severe late leptospirosis. Lancet, 8583, 433-435.
- Whang, R. & Ryder, K. W. (1990). Frequency of hypomagnesemia and hypermagnesemia. Requested vs routine. Journal of the American Medical Association, 263, 3063–3064.
- World Health Organization (2003). Human Leptospirosis: Guidance for Diagnosis, Surveillance and Control. Valletta: WHO.